|
1
|
Cevhertas L, Ogulur I, Maurer DJ, Burla D,
Ding M, Jansen K, Koch J, Liu C, Ma S, Mitamura Y, et al: Advances
and recent developments in asthma in 2020. Allergy. 75:3124–3146.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Papi A, Brightling C, Pedersen SE and
Reddel HK: Asthma. Lancet. 391:783–800. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bao W, Zhang Y, Zhang M, Bao A, Fei X,
Zhang X and Zhou X: Effects of ozone repeated short exposures on
the airway/lung inflammation, airway hyperresponsiveness and mucus
production in a mouse model of ovalbumin-induced asthma. Biomed
Pharmacother. 101:293–303. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Busse W, Kraft M, Rabe KF, Deniz Y, Rowe
PJ, Ruddy M and Castro M: Understanding the key issues in the
treatment of uncontrolled persistent asthma with type 2
inflammation. Eur Respir J. 58:20033932021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Piñeros YS, Bal SM, Dijkhuis A, Majoor CJ,
Dierdorp BS, Dekker T, Hoefsmit EP, Bonta PI, Picavet D, van der
Wel NN, et al: Eosinophils capture viruses, a capacity that is
defective in asthma. Allergy. 74:1898–1909. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Reddel HK, Bateman ED, Becker A, Boulet
LP, Cruz AA, Drazen JM, Haahtela T, Hurd SS, Inoue H, de Jongste
JC, et al: A summary of the new GINA strategy: A roadmap to asthma
control. Eur Respir J. 46:622–639. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Heffler E, Madeira LNG, Ferrando M,
Puggioni F, Racca F, Malvezzi L, Passalacqua G and Canonica GW:
Inhaled corticosteroids safety and adverse effects in patients with
asthma. J Allergy Clin Immunol Pract. 6:776–781. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu Y and Eissa NT: Autophagy in innate and
adaptive immunity. Proc Am Thorac Soc. 7:22–28. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Levine B, Mizushima N and Virgin HW:
Autophagy in immunity and inflammation. Nature. 469:323–335. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang S, Wuniqiemu T, Tang W, Teng F, Bian
Q, Yi L, Qin J, Zhu X, Wei Y and Dong J: Luteolin inhibits
autophagy in allergic asthma by activating PI3K/Akt/mTOR signaling
and inhibiting Beclin-1-PI3KC3 complex. Int Immunopharmacol.
94:1074602021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hill S, Wrobel L and Rubinsztein D:
Post-translational modifications of Beclin 1 provide multiple
strategies for autophagy regulation. Cell Death Differ. 26:617–629.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matsuzawa-Ishimoto Y, Hwang S and Cadwell
K: Autophagy and Inflammation. Ann Rev Immunol. 36:73–101. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kirkin V, McEwan D, Novak I and Dikic I: A
role for ubiquitin in selective autophagy. Mol Cell. 34:259–269.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Deretic V: Autophagy in inflammation,
infection, and immunometabolism. Immunity. 54:437–453. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Racanelli AC, Kikkers SA, Choi AMK and
Cloonan SM: Autophagy and inflammation in chronic respiratory
disease. Autophagy. 14:221–232. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Renz H: Autophagy: Nobel prize 2016 and
allergy and asthma research. J Allergy Clin Immunol. 140:1548–1549.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Silveira JS, Antunes GL, Kaiber DB, da
Costa MS, Ferreira FS, Marques EP, Schmitz F, Gassen RB, Breda RV,
Wyse ATS, et al: Autophagy induces eosinophil extracellular traps
formation and allergic airway inflammation in a murine asthma
model. J Cell Physiol. 235:267–280. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu JN, Suh DH, Trinh HK, Chwae YJ, Park
HS and Shin YS: The role of autophagy in allergic inflammation: A
new target for severe asthma. Exp Mol Med. 48:e2432016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McAlinden KD, Deshpande DA, Ghavami S,
Xenaki D, Sohal SS, Oliver BG, Haghi M and Sharma P: Autophagy
activation in asthma airways remodeling. Am J Respir Cell Mol Biol.
60:541–553. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chan HHL and Ng T: Traditional Chinese
medicine (TCM) and allergic diseases. Curr Allergy Asthma Rep.
20:672020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang W, Liu QB and Jing W: Astragalus
membranaceus improves therapeutic efficacy of asthmatic children by
regulating the balance of Treg/Th17 cells. Chin J Nat Med.
17:252–263. 2019.PubMed/NCBI
|
|
22
|
Wang W, Jing W and Liu Q: Astragalus oral
solution ameliorates allergic asthma in children by regulating
relative contents of CD4+ CD25high
CD127low treg cells. Front Pediatr. 6:2552018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li L, Hou X, Xu R, Liu C and Tu M:
Research review on the pharmacological effects of astragaloside IV.
Fundam Clin Pharmacol. 31:17–36. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li K, Chen Y, Jiang R, Chen D, Wang H,
Xiong W, Li D, Liu Z, Li X, Li J and Yuan K: Protective effects of
astragaloside IV against ovalbumin-induced allergic rhinitis are
mediated by T-box protein expressed in T cells/GATA-3 and forkhead
box protein 3/retinoic acid-related orphan nuclear receptor γt. Mol
Med Rep. 16:1207–1215. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang X, Tang L, Wang F and Song G:
Astragaloside IV attenuates allergic inflammation by regulation
Th1/Th2 cytokine and enhancement CD4(+)CD25(+)Foxp3 T cells in
ovalbumin-induced asthma. Immunobiology. 219:565–571. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Calis I, Gazar H, Piacente S and Pizza C:
Secondary metabolites from the roots of Astragalus zahlbruckneri. J
Nat Prod. 64:1179–1182. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu Y, Zhou L, Yang Y and Liu Y:
Cycloastragenol: An exciting novel candidate for age-associated
diseases. Exp Ther Med. 16:2175–2182. 2018.PubMed/NCBI
|
|
28
|
Wan Y, Xu L, Wang Y, Tuerdi N, Ye M and Qi
R: Preventive effects of astragaloside IV and its active sapogenin
cycloastragenol on cardiac fibrosis of mice by inhibiting the NLRP3
inflammasome. Eur J Pharmacol. 833:545–554. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Melgert BN, Postma DS, Kuipers I,
Geerlings M, Luinge MA, van der Strate BW, Kerstjens HAM, Timens W
and Hylkema MN: Female mice are more susceptible to the development
of allergic airway inflammation than male mice. Clin Exp Allergy.
35:1496–1503. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Y, Chen S, Chi Y, Yang Y, Chen X, Wang
H, Lv Z, Wang J, Yuan L, Huang P, et al: Kinetics of the
accumulation of group 2 innate lymphoid cells in IL-33-induced and
IL-25-induced murine models of asthma: A potential role for the
chemokine CXCL16. Cell Mol Immunol. 16:75–86. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Peng H, Ning H, Wang Q, Lu W, Chang Y,
Wang TT, Lai J, Kolattukudy PE, Hou R, Hoft DF, et al: Monocyte
chemotactic protein-induced protein 1 controls allergic airway
inflammation by suppressing IL-5-producing TH 2 cells
through the Notch/Gata3 pathway. J Allergy Clin Immunol.
142:582–594. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen S, Yun F, Yao Y, Cao M, Zhang Y, Wang
J, Song X and Qian Y: USP38 critically promotes asthmatic
pathogenesis by stabilizing JunB protein. J Exp Med. 215:2850–2867.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tel BC, Telli G, Onder S, Nemutlu E and
Bozkurt TE: Investigation of the relationship between chronic
montelukast treatment, asthma and depression-like behavior in mice.
Exp Ther Med. 21:272021.PubMed/NCBI
|
|
34
|
Tamaru S, Mishina H, Watanabe Y, Watanabe
K, Fujioka D, Takahashi S, Suzuki K, Nakamura T, Obata JE, Kawabata
K, et al: Deficiency of phospholipase A2 receptor exacerbates
ovalbumin-induced lung inflammation. J Immunol. 191:1021–1028.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim S, Thiessen PA, Bolton EE, Chen J, Fu
G, Gindulyte A, Han L, He J, He S, Shoemaker BA, et al: PubChem
substance and compound databases. Nucleic Acids Res.
44:D1202–D1213. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Berman H, Westbrook J, Feng Z, Gilliland
G, Bhat TN, Weissig H, Shindyalov IN and Bourne PE: The protein
data bank. Nucleic Acids Res. 28:235–242. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Morris G, Huey R, Lindstrom W, Sanner MF,
Belew RK, Goodsell DS and Olson AJ: AutoDock4 and AutoDockTools4:
Automated docking with selective receptor flexibility. J Comput
Chem. 30:2785–2791. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Trott O and Olson A: AutoDock vina:
Improving the speed and accuracy of docking with a new scoring
function, efficient optimization, and multithreading. J Comput
Chem. 31:455–461. 2010.PubMed/NCBI
|
|
39
|
Seeliger D and de Groot B: Ligand docking
and binding site analysis with PyMOL and autodock/vina. J Comput
Aided Mol Des. 24:417–422. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang C, Tu M, Wu D, Chen H, Chen C, Wang Z
and Jiang L: Identification of an ACE-inhibitory peptide from
walnut protein and its evaluation of the inhibitory mechanism. Int
J Mol Sci. 19:11562018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Feng FB and Qiu HY: Effects of Artesunate
on chondrocyte proliferation, apoptosis and autophagy through the
PI3K/AKT/mTOR signaling pathway in rat models with rheumatoid
arthritis. Biomed Pharmacother. 102:1209–1220. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wei Y, Liu B, Sun J, Lv Y, Luo Q, Liu F
and Dong J: Regulation of Th17/Treg function contributes to the
attenuation of chronic airway inflammation by icariin in
ovalbumin-induced murine asthma model. Immunobiology. 220:789–797.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tang W, Dong M, Teng F, Cui J, Zhu X, Wang
W, Wuniqiemu T, Qin J, Yi L, Wang S, et al: TMT-based quantitative
proteomics reveals suppression of SLC3A2 and ATP1A3 expression
contributes to the inhibitory role of acupuncture on airway
inflammation in an OVA-induced mouse asthma model. Biomed
Pharmacother. 134:1110012021. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kubo M: Innate and adaptive type 2
immunity in lung allergic inflammation. Immunol Rev. 278:162–172.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhu X, Cui J, Yi L, Qin J, Tulake W, Teng
F, Tang W, Wei Y and Dong J: The role of T cells and macrophages in
asthma pathogenesis: A new perspective on mutual crosstalk.
Mediators Inflamm. 2020:78352842020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bleecker ER, Menzies-Gow AN, Price DB,
Bourdin A, Sweet S, Martin AL, Alacqua M and Tran TN: Systematic
literature review of systemic corticosteroid use for asthma
management. Am J Respir Crit Care Med. 201:276–293. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhu J, Lee S, Ho MK, Hu Y, Pang H, Ip FC,
Chin AC, Harley CB, Ip NY and Wong YH: In vitro intestinal
absorption and first-pass intestinal and hepatic metabolism of
cycloastragenol, a potent small molecule telomerase activator. Drug
Metab Pharmacokinet. 25:477–486. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li M, Li SC, Dou BK, Zou YX, Han HZ, Liu
DX, Ke ZJ and Wang ZF: Cycloastragenol upregulates SIRT1
expression, attenuates apoptosis and suppresses neuroinflammation
after brain ischemia. Acta Pharmacol Sin. 41:1025–1032. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gu M, Zhang S, Zhao Y, Huang J, Wang Y, Li
Y, Fan S, Yang L, Ji G, Tong Q and Huang C: Cycloastragenol
improves hepatic steatosis by activating farnesoid X receptor
signalling. Pharmacol Res. 121:22–32. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang Y, Chen C, Wang Q, Cao Y, Xu L and Qi
R: Inhibitory effects of cycloastragenol on abdominal aortic
aneurysm and its related mechanisms. Br J Pharmacol. 176:282–296.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Liu J, Gao D, Dan J, Liu D, Peng L, Zhou R
and Luo Y: The protective effect of cycloastragenol on aging mouse
circadian rhythmic disorder induced by d-galactose. J Cell Biochem.
120:16408–16415. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Deng G, Chen W, Wang P, Zhan T, Zheng W,
Gu Z, Wang X, Ji X and Sun Y: Inhibition of NLRP3
inflammasome-mediated pyroptosis in macrophage by cycloastragenol
contributes to amelioration of imiquimod-induced psoriasis-like
skin inflammation in mice. Int Immunopharmacol. 74:1056822019.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kanehiro A, Takeda K, Joetham A, Tomkinson
A, Ikemura T, Irvin CG and Gelfand EW: Timing of administration of
anti-VLA-4 differentiates airway hyperresponsiveness in the central
and peripheral airways in mice. Am J Respir Crit Care Med.
162:1132–1139. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Dong L, Wang Y, Zheng T, Pu Y, Ma Y, Qi X,
Zhang W, Xue F, Shan Z, Liu J, et al: Hypoxic hUCMSC-derived
extracellular vesicles attenuate allergic airway inflammation and
airway remodeling in chronic asthma mice. Stem Cell Res Ther.
12:42021. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Hammad H and Lambrecht BN: The basic
immunology of asthma. Cell. 184:1469–1485. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Chen W, Sivaprasad U, Gibson AM, Ericksen
MB, Cunningham CM, Bass SA, Kinker KG, Finkelman FD, Wills-Karp M
and Hershey GK: IL-13 receptor α2 contributes to development of
experimental allergic asthma. J Allergy Clin Immunol. 132:951–958.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lambrecht BN, Hammad H and Fahy JV: The
cytokines of asthma. Immunity. 50:975–991. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Gould HJ and Sutton BJ: IgE in allergy and
asthma today. Nat Rev Immunol. 8:205–217. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wang J, Wu ML, Cao SP, Cai H, Zhao ZM and
Song YH: Cycloastragenol ameliorates experimental heart damage in
rats by promoting myocardial autophagy via inhibition of
AKT1-RPS6KB1 signaling. Biomed Pharmacother. 107:1074–1081. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Cadwell K: Crosstalk between autophagy and
inflammatory signalling pathways: Balancing defence and
homeostasis. Nat Rev Immunol. 16:661–675. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Mizushima N and Levine B: Autophagy in
human diseases. N Engl J Med. 383:1564–1576. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Maneechotesuwan K, Kasetsinsombat K,
Wongkajornsilp A and Barnes PJ: Role of autophagy in regulating
interleukin-10 and the responses to corticosteroids and statins in
asthma. Clin Exp Allergy. 19:138252021. View Article : Google Scholar
|
|
63
|
Xia F, Deng C, Jiang Y, Qu Y, Deng J, Cai
Z, Ding Y, Guo Z and Wang J: IL4 (interleukin 4) induces autophagy
in B cells leading to exacerbated asthma. Autophagy. 14:450–464.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zhang Y, Do DC, Hu X, Wang J, Zhao Y,
Mishra S, Zhang X, Wan M and Gao P: CaMKII oxidation regulates
cockroach allergen-induced mitophagy in asthma. J Allergy Clin
Immunol. 147:1464–1477. 2021. View Article : Google Scholar : PubMed/NCBI
|
